230 related articles for article (PubMed ID: 9835982)
21. Biological function of cholinesterase.
Kutty KM
Clin Biochem; 1980 Dec; 13(6):239-43. PubMed ID: 7011592
[No Abstract] [Full Text] [Related]
22. The effect of fluoride and hypothermia on the in vitro metabolism of mivacurium.
Gruber M; Lindner R; Prasser C; Wiesner G
Anesth Analg; 2002 Aug; 95(2):397-9, table of contents. PubMed ID: 12145059
[TBL] [Abstract][Full Text] [Related]
23. Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.
Gätke MR; Bundgaard JR; Viby-Mogensen J
Pharmacogenet Genomics; 2007 Nov; 17(11):995-9. PubMed ID: 18075469
[TBL] [Abstract][Full Text] [Related]
24. Role of cholinesterase activity on pharmacodynamics of mivacurium preceded by pancuronium in elderly and young adults.
Osman ES; Khafagy HF; Radwan KG; Desouky AM
J Egypt Soc Parasitol; 2007 Apr; 37(1):243-55. PubMed ID: 17580581
[TBL] [Abstract][Full Text] [Related]
25. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine.
Cook DR; Stiller RL; Weakly JN; Chakravorti S; Brandom BW; Welch RM
Anesth Analg; 1989 Apr; 68(4):452-6. PubMed ID: 2522748
[TBL] [Abstract][Full Text] [Related]
26. Prolonged response to succinylcholine: a new variant of plasma cholinesterase that is identified as normal by traditional phenotyping methods.
Greenberg CP; Primo-Parmo SL; Pantuck EJ; la Du BN
Anesth Analg; 1995 Aug; 81(2):419-21. PubMed ID: 7618741
[No Abstract] [Full Text] [Related]
27. [Prolonged mivacurium induced neuromuscular block in 5 patients homozygotic for atypical butyrylcholinesterase phenotype].
Burnat P; Soulard D; Jacquel A; Coste T; Le Marchand P; Benoist JF
Ann Fr Anesth Reanim; 1995; 14(6):532. PubMed ID: 8745981
[No Abstract] [Full Text] [Related]
28. Human cholinesterase (pseudocholinesterase): genetic variants and their recognition.
Lehmann H; Liddell J
Br J Anaesth; 1969 Mar; 41(3):235-44. PubMed ID: 5776668
[No Abstract] [Full Text] [Related]
29. Suxamethonium and mivacurium sensitivity from pregnancy-induced plasma cholinesterase deficiency.
Davies P; Landy M
Anaesthesia; 1998 Nov; 53(11):1109-11. PubMed ID: 10023281
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel butyrylcholinesterase point mutation (p.Ala34Val), "silent" with mivacurium.
Delacour H; Lushchekina S; Mabboux I; Ceppa F; Masson P; Schopfer LM; Lockridge O
Biochem Pharmacol; 2014 Dec; 92(3):476-83. PubMed ID: 25264279
[TBL] [Abstract][Full Text] [Related]
31. [Prolonged phase II neuromuscular blockade following succinylcholine administration].
Jurkolow G; Fuchs-Buder T; Lemoine A; Raft J; Rocq N; Meistelman C
Ann Fr Anesth Reanim; 2014 Mar; 33(3):176-7. PubMed ID: 24440731
[TBL] [Abstract][Full Text] [Related]
32. Frequency of butyrylcholinesterase gene mutations in individuals with abnormal inhibition numbers: an Italian-population study.
Lando G; Mosca A; Bonora R; Azzario F; Penco S; Marocchi A; Panteghini M; Patrosso MC
Pharmacogenetics; 2003 May; 13(5):265-70. PubMed ID: 12724618
[TBL] [Abstract][Full Text] [Related]
33. Analysis of mutations in the plasma cholinesterase gene of patients with a history of prolonged neuromuscular block during anesthesia.
Barta C; Sasvari-Szekely M; Devai A; Kovacs E; Staub M; Enyedi P
Mol Genet Metab; 2001 Dec; 74(4):484-8. PubMed ID: 11749053
[TBL] [Abstract][Full Text] [Related]
34. [Prolonged neuromuscular blockade with mivacurium in a newborn].
Doucet O; Martin L; Laffon M; Jonville-Bera AP; Mercier C
Ann Fr Anesth Reanim; 1998; 17(7):725-7. PubMed ID: 9750810
[TBL] [Abstract][Full Text] [Related]
35. [Antagonists of neuromuscular blockade--mechanisms of action, adverse effects and dosages].
Schuh FT
Klin Anasthesiol Intensivther; 1980; 22():158-74. PubMed ID: 6108384
[No Abstract] [Full Text] [Related]
36. Butyrylcholinesterase deficiency and its clinical importance in anaesthesia: a systematic review.
Andersson ML; Møller AM; Wildgaard K
Anaesthesia; 2019 Apr; 74(4):518-528. PubMed ID: 30600548
[TBL] [Abstract][Full Text] [Related]
37. Prolonged neuromuscular block due to cholinesterase depletion by plasmapheresis.
Naik B; Hirshhorn S; Dharnidharka VR
J Clin Anesth; 2002 Aug; 14(5):381-4. PubMed ID: 12208445
[TBL] [Abstract][Full Text] [Related]
38. Train-of-four nerve stimulation in the management of prolonged neuromuscular blockade following succinylcholine.
Savarese JJ; Ali HH; Murphy JD; Padget C; Lee CM; Ponitz J
Anesthesiology; 1975 Jan; 42(1):106-11. PubMed ID: 122883
[TBL] [Abstract][Full Text] [Related]
39. Timing of blood sampling for butyrylcholinesterase phenotyping in patients with prolonged neuromuscular block after mivacurium or suxamethonium.
Mintjens N; Brummans R; Soetens F; Claes KBM; Vanlinthout LE
Acta Anaesthesiol Scand; 2021 Feb; 65(2):182-187. PubMed ID: 33010031
[TBL] [Abstract][Full Text] [Related]
40. Predictors of the variability in neuromuscular block duration following succinylcholine: A prospective, observational study.
Dell-Kuster S; Levano S; Burkhart CS; Lelais F; Zemp A; Schobinger E; Hampl K; Kindler C; Girard T
Eur J Anaesthesiol; 2015 Oct; 32(10):687-96. PubMed ID: 26213905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
